Vedolizumab and Infliximab Combination Therapy in the Treatment of Crohn's Disease

Am J Gastroenterol. 2015 Dec;110(12):1737-8. doi: 10.1038/ajg.2015.355.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Crohn Disease / diagnosis*
  • Crohn Disease / drug therapy*
  • Crohn Disease / pathology
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Gastrointestinal Agents / therapeutic use*
  • Humans
  • Infliximab / therapeutic use*
  • Male
  • Natalizumab / therapeutic use
  • Remission Induction
  • Sigmoidoscopy
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Antibodies, Monoclonal, Humanized
  • Gastrointestinal Agents
  • Natalizumab
  • Tumor Necrosis Factor-alpha
  • vedolizumab
  • Infliximab